≡

Multiplex Assay Kit for Activin B (ACVB) ,etc. by FLIA (Flow Luminescence Immunoassay)

ACV-B; Activin Beta B Beta B Homodimer

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Activin B (ACVB) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Activin B (ACVB) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Activin B (ACVB) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Activin B (ACVB) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-101 90
EDTA plasma(n=5) 89-96 92
heparin plasma(n=5) 86-99 92

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Activin B (ACVB) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Activin B (ACVB) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Activin B (ACVB) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-98% 79-104% 93-103% 86-101%
EDTA plasma(n=5) 83-97% 92-99% 92-101% 79-99%
heparin plasma(n=5) 88-96% 81-92% 88-95% 80-96%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:ACVB) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Gastroenterology Research and Practice Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report. Pubmed: 24799891
Gastroenterol Res Pract.? Serum activins and follistatin during the treatment of chronic hepatitis c genotypes 1 and 4 and their correlations with viral load and liver enzymes: A preliminary report Pubmed:Pmc3995172
Clin Exp Med.? Effects?of?chronic hepatitis C?genotype?1?and 4 on serum activins and follistatin in treatment na?ve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage. Pubmed:24925642
Clin Biochem Serum activin B concentration as predictive biomarker for ectopic pregnancy Pubmed:26968108
BMC Cancer. Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer. pubmed:27835986
Australasian Journal of Ultrasound in Medicine The potential value of activin B and fibronectin for the triage of pregnancies of unknown location and prediction of first trimester viability 10.1002:ajum.12090
Pathology & Oncology Research Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status 34867090
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
SEA170Hu ELISA Kit for Activin B (ACVB) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA170Hu Multiplex Assay Kit for Activin B (ACVB) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.